Eravacycline as Salvage Therapy for Severe Intra-Abdominal Infections Caused by Multidrug-Resistant <i>Acinetobacter baumannii</i>: A Case Series
<b>Background/Objectives</b>: Infections due to multidrug-resistant (MDR) <i>Acinetobacter baumannii</i> represent a critical challenge in modern healthcare, with limited therapeutic options. Eravacycline, a novel fluorocycline antibiotic, demonstrates promising in vitro activity, but real-world cli...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI AG
2026-01-01
|
| Edice: | Antibiotics |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/2079-6382/15/1/93 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
